Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2026-01-04 @ 5:34 PM
Study NCT ID:
NCT05462535
Status:
COMPLETED
Last Update Posted:
2022-07-18
First Post:
2022-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet
Sponsor:
Hanmi Pharmaceutical Company Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-14
First Submit QC Date:
None
Study First Post Date:
2022-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-14
Last Update Post Date:
2022-07-18
Last Update Post Date Type:
ACTUAL